全文获取类型
收费全文 | 2303篇 |
免费 | 123篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 116篇 |
妇产科学 | 44篇 |
基础医学 | 243篇 |
口腔科学 | 48篇 |
临床医学 | 157篇 |
内科学 | 459篇 |
皮肤病学 | 25篇 |
神经病学 | 108篇 |
特种医学 | 322篇 |
外科学 | 288篇 |
综合类 | 167篇 |
一般理论 | 1篇 |
预防医学 | 89篇 |
眼科学 | 65篇 |
药学 | 184篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 125篇 |
出版年
2023年 | 16篇 |
2021年 | 44篇 |
2020年 | 28篇 |
2019年 | 34篇 |
2018年 | 48篇 |
2017年 | 29篇 |
2016年 | 35篇 |
2015年 | 33篇 |
2014年 | 65篇 |
2013年 | 84篇 |
2012年 | 117篇 |
2011年 | 123篇 |
2010年 | 87篇 |
2009年 | 84篇 |
2008年 | 106篇 |
2007年 | 130篇 |
2006年 | 94篇 |
2005年 | 78篇 |
2004年 | 82篇 |
2003年 | 69篇 |
2002年 | 52篇 |
2001年 | 55篇 |
2000年 | 68篇 |
1999年 | 51篇 |
1998年 | 58篇 |
1997年 | 51篇 |
1996年 | 49篇 |
1995年 | 34篇 |
1994年 | 24篇 |
1993年 | 23篇 |
1992年 | 25篇 |
1991年 | 32篇 |
1990年 | 30篇 |
1989年 | 48篇 |
1988年 | 42篇 |
1987年 | 28篇 |
1986年 | 43篇 |
1985年 | 35篇 |
1984年 | 27篇 |
1983年 | 21篇 |
1982年 | 28篇 |
1981年 | 15篇 |
1980年 | 19篇 |
1979年 | 25篇 |
1978年 | 24篇 |
1977年 | 23篇 |
1976年 | 21篇 |
1975年 | 14篇 |
1973年 | 12篇 |
1972年 | 12篇 |
排序方式: 共有2461条查询结果,搜索用时 0 毫秒
71.
72.
Singanamalla Bhanudeep Mohandoss Vichithra Suthar Renu Ahuja Chirag Kamal Sahu Jitendra Kumar 《Indian journal of pediatrics》2020,87(6):466-467
Indian Journal of Pediatrics - 相似文献
73.
目的:已有理论提出急性心肌梗死后骨髓和外周血中的CD34 干细胞具有自身动员的潜能,观察这一潜能的变化特征及其对心肌梗死组织再生能力的影响。方法:实验于2004-09/2005-02在阜外心血管病医院完成。①实验动物:雄性SD大鼠40只,随机数字表法分为心肌梗死组、假手术组,20只/组。②实验方法:心肌梗死组大鼠采用冠状动脉结扎法建立心肌梗死模型。心电图ST段抬高或有室性心律出现,前壁心肌呈苍白色为造模成功。假手术组仅作开胸手术,前降支不予结扎。③实验评估:于心肌梗死后3,7,14,28d,流式细胞仪检测骨髓和外周血中CD34 干细胞的含量。用免疫组化方法检测梗死心肌组织中的Ki67细胞和毛细血管数量。结果:①外周血及骨髓CD34 干细胞含量的变化:心肌梗死组外周血中的CD34 干细胞数量于造模后3d开始上升,7d后明显高于假手术组(P<0.01),至14,28d时逐渐回落至假手术组水平(P>0.05)。心肌梗死组骨髓中的CD34 干细胞数量于造模后各时间点始终无明显变化(P>0.05)。②组织学评定:心肌梗死组梗死区Ki67细胞和毛细血管数量于造模后3d开始增多,7d时明显多于非梗死区(P<0.05);至14,28d梗死区Ki67细胞数量明显少于造模后7d(P<0.05),毛细血管数量的减少不明显(P>0.05)。免疫组化染色显示少数Ki67细胞分化为血管内皮细胞,未见向心肌细胞分化。③相关性分析:梗死区Ki67细胞、毛细血管数量于造模后7d与外周血中CD34 干细胞数量呈显著正相关(r=0.913,P=0.021;r=0.887,P=0.035)。结论:机体CD34 干细胞的自体动员、增殖反应的潜能随急性心肌梗死时间的延长而逐渐减弱,自体动员的干细胞功能尚不足以达到修复梗死心肌组织的效果。 相似文献
74.
Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors 总被引:6,自引:0,他引:6
NL Dock ; HV Lamberson Jr ; TA O''Brien ; DE Tribe ; SS Alexander ; BJ Poiesz 《Transfusion》1988,28(5):412-418
Blood donors reactive by enzyme-linked immunosorbent assay for antibody to the human immunodeficiency virus (HIV) who showed atypical patterns of viral core protein reactivity on Western blot were monitored for several months. Characterization of their antibodies was performed by 1) use of recombinant HIV proteins; 2) determination of cross-reactivity to HTLV-I, HTLV-II, and HTLV-IV: 3) assessment of immune status; and 4) identification of potentially interfering autoantibodies. Nineteen of 20 donors maintained the same HIV antibody reactivity throughout the follow-up period; the other donor became fully antibody-positive. Eighteen of 20 donors' sera showed clear reactivity with HIV recombinant core proteins. Ten of 19 donor samples demonstrated cross-reactivity to HTLV-IV; 3 of these 10 also cross-reacted with HTLV-I. The immune status of all donors was normal, although the medical histories and HLA antibody screens suggested possible autoimmune reactivity in 9 of 18 donors. During follow-up interviews, three donors reported possible risk factors for HIV infection that had not been acknowledged at the time of blood donation. We conclude that exclusion of donors with these atypical serologic test results is warranted while further studies to determine significance are being conducted. 相似文献
75.
76.
Jin He Barish H. Edil John L. Cameron Richard D. Schulick Ralph H. Hruban Joseph M. Herman Lei Zheng Christine Iacobuzio-Donahue Nita Ahuja Timothy M. Pawlik Christopher L. Wolfgang 《Journal of gastrointestinal surgery》2013,17(2):339-344
Background
The median age of pancreatic ductal adenocarcinoma (PDAC) patients is 71 years. PDAC rarely affects individuals under the age of 45. We investigated features of PDAC occurring in young patients (≤45 years) who underwent surgical resection in order to determine if any difference exists in comparison to elderly patients (≥70 years).Methods
A retrospective analysis of patients with PDAC who were?≤?45 years on the date of surgery between 1975 and 2009 was performed. This cohort was compared with PDAC patients whose ages were over 70 years on the date of surgery over the same time interval. Information reviewed included demographics, Charlson Age–Comorbidity Index (CACI), pathological staging, surgical management, and death or last follow-up.Results
Seventy five patients with PDAC of age?≤?45 years at surgery were identified. The reference group consisted of 870 patients with a median age of 75. The most common symptoms of young patients were jaundice (45 %), abdominal pain (32 %), or weight loss (33 %). This did not differ significantly from older patients. Among the younger patients, 7 (9 %) underwent total pancreatectomy, 60 (80 %) underwent pancreaticoduodenectomy, and 8 (11 %) had distal pancreatectomy. The distribution of type of surgery was similar between two groups. Fifty-two of the young patients (69 %) had an R0 resection and this did not differ from the older age group (n?=?616; 71 %). The rate of lymph node positivity was 68 % for younger patients and 74 % for older patients (p?=?0.27). Of the younger patients, 11, 13, 49, and 2 were classified as stage I, IIA, IIB, and III, respectively, and did not differ from the older age group. The median overall survival for the young patients cohort was 19 months (95 % CI 15–22 months) which is longer than 16 months (95 % CI 14–17 months) of the older group (p?=?0.007). The actual 5- and 10- year survival in young age group (24 and 17 %) was longer than that in old age group (11 and 3 %) (p?<?0.05). The median CACI of the younger patients was 0.5 and was lower than 4.1 of the older patients (p?<?0.0001).Conclusions
The demographic, pathologic, and treatment characteristics of PDAC patients younger than 45 years were similar to those older than 70 years. Younger patients had fewer complications after curative resections. The better survival among younger patients is likely related to fewer comorbidities in this group. These findings will be useful in counseling young patients with resectable pancreatic cancer. 相似文献77.
Uday Eknathrao Jadhav M.Ch. Raghavendra Chikkatur M.Ch. Rajesh Parida M.Ch. Susheel Kumar M.Ch. Vinod Ahuja M.Ch. Ashish Agrawal MS Anil Tendolkai M.Ch. 《Indian Journal of Thoracic and Cardiovascular Surgery》2006,22(2):116-120
Introduction Coronary artery bypass grafting (CABG) associated with Endarterectomy is a high risk procedure. After the first report of
coronary endarterectomy by Bailey et al in 1951, the preference for this surgical procedure was decreased due to increased
morbidity and mortality In patients with total or subtotal large coronary artery obstructions in which there is no possibility
to receive a conduit as graft for myocardial revascularisation, endarterectomy remains the procedure of choice. This study
was designed to study early and midterm results of off pump coronary artery endarterectomy.
Methods Of 172 Consecutive Off Pump CABG done at our institution from Jan 2003 to July 2005, 22 patients underwent supplementary coronary
endarterectomy. 16 patients had chronic stable angina 4 had unstable angina two required emergency CABG with endarterectomy
following perioperative infarction. The mean ejection fraction was 29.2±4.3 and all of the patients were in New York Heart
Association (NYHA) III or IV. All patients were planned for complete total arterial revascularisation using Left Internal
Mammary Artery (LIMA). Right Internal Mammary Artery (RIMA), Radial composite “Y” graft, Two patients operated for periop
infarct received vein graft. In 16 patients closed endarterectomy was done in five patients double endarterectomy in single
vessel was done to chase the plaque distally, in one patient open left anterior descending (LAD) endarterectomy with vein
patch reconstruction was performed.
Results There were no deaths. None of the procedures were converted to on pump operation. All endarterectomies and bypasses were performed
on Beating Heart, all patients were completely revascularised. Peri operative cardiac enzymes studied showed no significant
rise in the Creatinine Phoshpokinase (CPK)-Creatinine Phosphokinase myocardial Band (CPK-MB). The mean postoperative Ejection
Fraction (EF) was 36.7%±7.2% which was significantly higher than the Preoperative one (p<.05). At the end of four months to
one and half year 22 patients were in NYHA class I to II and all were angina free in canadian cardiovascular society class.f
Conclusions Coronary End Arterectomy without cardiopulmonary bypass can be performed in patients who are expected to benefit from complete
revascularisation. It can be performed with closed as well as open method. However to achieve complete endarterectomy by closed
technique in some patients it is essential to chase the plaque. Early and mid term results are encouraging. 相似文献
78.
BACKGROUND: The Centers for Disease Control and Prevention (CDC) recommends hepatitis B virus (HBV) immunization for all hemodialysis (HD) patients because they are at high risk of infection. Several studies have shown that the development of protective antibody titers after HBV vaccination is much lower in HD patients. We hypothesized that human immunodeficiency virus (HIV) infection in patients with end-stage renal disease (ESRD) would further impair the immune response to hepatitis B vaccination. METHODS: We performed a retrospective cohort study of patients undergoing long-term hemodialysis from 1990 to 2002 at the United States-based dialysis facilities of Gambro Corporation, North America. The response rate defined as an increase in anti-HBs levels >/=10 mIU/L after a month of the third dose of HBV vaccination was determined in HIV-infected and a randomly selected group of ESRD patients. The demographic information, laboratory data, and hepatitis B surface antibody (anti-HBs) titers were recorded from the Gambro Corporation database on these patients. RESULTS: Of the 347 adult HIV ESRD patients, 116 received three doses of recombinant hepatitis B vaccination. Seventy percent were male, and the majority (86%) were black. Of the 116 patients who received three doses of HBV vaccination, 62 (53.4%) developed protective antibody titers. This was comparable to the response rate of 50.4% in the randomly selected 220 non-HIV hemodialysis patients. Among HIV ESRD patients, the mean hemoglobin (Hgb) was higher in patients who developed protective antibody titers (Hgb 11.61 +/- 2 vs. 10.55 +/- 1.86, P value <0.01). On multivariate logistic regression analysis, higher Hgb was associated with protective antibody titers (odds ratio: 1.34, 95% CI 0.99-1.72). Seventy percent of the HIV-infected responders maintained protective antibody titers 6 months after vaccination. CONCLUSION: Hepatitis B vaccination should be offered to all HIV-infected ESRD patients because over half of the patients with HIV and ESRD can develop protective antibodies. 相似文献
79.
背景和目的:最近的研究结果表明,对其他一线药物和注射类药物(如卡那霉素、卷曲霉素)等耐药是影响耐多药结核病(MDR-TB)患者治疗效果的独立危险因素.本研究旨在明确耐其他一线药物和注射类药物对韩国不合并人免疫缺陷病毒(HIV)感染的MDR-TB患者临床疗效的影响.方法:采用回顾性队列研究分析1996年1月至2005年12月首尔国家大学附属医院治疗的211例MDR-TB患者治疗效果,排除7例丢失和7例迁出,对197例患者进行了最终分析. 相似文献
80.